STAT5B and Chronic Eosinophilic Leukemia, Not Otherwise Specified: The overall survival of STAT5B-mutated HES cases was only 30 months, suggesting that these cases should be reclassified as chronic eosinophilic leukemia, not otherwise specified (CEL-NOS).